Molecules 2014, 19
5608
6. Byrne, A.J.; Barlow, J.W.; Walsh, J.J. Synthesis and pharmacological evaluation of the individual
stereoisomers of 3-[methyl(1,2,3,4-tetrahydro-2-naphthalenyl)amino]-1-indanone, a potent mast
cell stabilising agent. Bioorg. Med. Chem. Lett. 2011, 21, 1191–1194.
7. Saxena, H.O.; Faridi, U.; Srivastava, S.; Kumar, J.K.; Darokar, M.P.; Luqman, S.; Chanotiya, C.S.;
Krishna, V.; Negi, A.S.; Khanuja, S.P.S. Gallic acid-based indanone derivatives as anticancer
agents. Biorg. Med. Chem. Lett. 2008, 18, 3914–3918.
8. Schumann, H.; Stenzel, O.; Girgsdies, F. (–)-2-Menthylindenyl and (–)-2-menthyl-4,7-
dimethylindenyl complexes of rhodium, iridium, cobalt, and molybdenum. Organometallics 2001,
20, 1743–1751.
9. Herzog, M.N.; Chien, J.C.W.; Rausch, M.D. Novel 2-indenyl ansa-zirconocenes for the
polymerization of α-olefins. J. Organomet. Chem. 2002, 654, 29–35.
10. Leoni, L.M.; Hamel, E.; Genini, D.; Shih, H.; Carrera, C.J.; Cottam, H.M.; Carson, D.A.
Indanocine, a microtubule-binding indanone and a selective inducer of apoptosis in multidrug-
resistantm cancer cells. J. Natl. Cancer Inst. 2000, 92, 217–224.
11. Beukes, D.R.; Davies-Coleman, M.T.; Kelly-Borges, M.; Harper, M.K.; Faulkner, D.J.;
Dilemmaones, A.-C. Dilemmaones A−C, unusual indole alkaloids from a mixed collection of
South African Sponges. J. Nat. Prod. 1998, 61, 699–701.
12. Pellissier, H. Recent developments in the Nazarov process. Tetrahedron 2005, 61, 6479–6517.
13. Frontier, A.J.; Collinson, C. The Nazarov cyclization in organic synthesis. Recent advances.
Tetrahedron 2005, 61, 7577–7606.
14. Coyanis, E.M.; Panayides, J.L.; Fernandes, M.A.; de Koning, C.B.; van Ottoerlo, W.A.L.
Ring-closing metathesis for the synthesis of substituted indenols, indenones, indanones and
indenes: Tandem RCM-dehydrogenative oxidation and RCM-formal redox isomerization.
J. Organomet. Chem. 2006, 691, 5222–5224.
15. Clark, W.M.; Tickner-Eldridge, A.M.; Huang, G.K.; Pridgen, L.N.; Olsen, M.A.; Mills, R.J.;
Lantos, I.; Baine, N.H. A catalytic enantioselective synthesis of the endothelin receptor
antagonists SB-209670 and SB-217242. A base-catalyzed stereospecific formal 1,3-hydrogen
transfer of a chiral 3-arylindenol. J. Am. Chem. Soc. 1998, 120, 4550–4551.
16. Wang, G.; Zheng, C.; Zhao, G. Asymmetric reduction of substituted indanones and tetralones
catalyzed by chiral dendrimer and its application to the synthesis of (+)-sertraline. Tetrahedron:
Asymmetry 2006, 17, 2074–2081.
17. Kajiro, H.; Mitamura, S.; Mori, A.; Hiyama, T. Enantioselective synthesis of 2-hydroxy-1-
indanone, a key precursor of enantiomerically pure 1-amino-2-indanol. Tetrahedron: Asymmetry
1998, 9, 907–910.
18. Torisawa, Y.; Aki, S.; Minamikawa, J. Conversion of indanone oximes into isocarbostyrils.
Bioorg. Med. Chem. Lett. 2007, 17, 453–455.
19. Yadav, J.S.; Reddy, G.S.K.K.; Sabitha, G.; Krishna, A.D.; Prasad, A.R.; Rahaman, H.R.R.;
Rao, K.V.; Rao, A.B. Daucus carota and baker’s yeast mediated bio-reduction of prochiral
ketones. Tetrahedron: Asymmetry 2007, 18, 717–723.
20. Sharma, A.K.; Subramani, A.V.; Gorman, C.B. Efficient synthesis of halo indanones via
chlorosulfonic acid mediated Friedel-Crafts cyclization of aryl propionic acids and their use in
alkylation reactions. Tetrahedron 2007, 63, 389–395.